Tetrahydroisoquinoline quaternary ammonium salt derivatives, preparation method and analgesic use thereof
A technology of tetrahydroisoquinoline and derivatives, applied in the field of κ-opioid receptor agonists in analgesia, tetrahydroisoquinoline quaternary ammonium salt derivatives, to achieve strong analgesic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] 1-Methyl-1-((2-(6-chloro-3-oxo-2,3-dihydro-1H-indene-1-formyl)-1,2,3,4-tetrahydro iodide Isoquinolin-1-yl)-methyl)pyrrolium (I-1)
[0037] With reference to the method of Chinese patent CN1887872, using phenethylamine and 3-chlorobenzaldehyde as raw materials, 1-(tetrahydropyrrole-1-methyl)-2-(6-chloro-3-oxo-2,3 is prepared -Dihydro-1H-indene-1-formyl)-1,2,3,4-tetrahydroisoquinoline.
[0038] Add 1-(tetrahydropyrrole-1-methyl)-2-(6-chloro-3-oxo-2,3-dihydro-1H-indene-1-formyl)-1 to the 50ml eggplant-shaped bottle, 2,3,4-Tetrahydroisoquinoline (0.2g, 0.49mmol), acetone 10ml, methyl iodide (0.31ml, 49mmol), stirred at room temperature for 2h, a large amount of solid was precipitated, filtered to obtain white solid I-1, yield 77.4 %, m.p.170~172℃.
[0039] 1 H-NMR (300MHz, DMSO-d 6 ),δ(ppm):1.98~2.08(4H,m,2×CH 2 ),2.74~2.80(1H,d,J=15.9Hz,1 / 2CH 2 ),2.93~3.15(4H,m,2×1 / 2CH 2 ,CH 2 ),3.11(3H,s,NCH 3 ),3.48~3.79(4H,m,2×CH 2 ),3.92~4.06,4.13~4.32(2H,m,2×1 / 2CH 2 ),4.63...
Embodiment 2
[0041]1-Methyl-1-((2-(6-chloro-3-oxo-2,3-dihydro-1H-indene-1-formyl)-7-fluoro-1,2,3 iodide ,4-Tetrahydroisoquinolin-1-yl)-methyl)pyrrolium (I-2)
[0042] With reference to the method of Chinese patent CN1887872, 4-fluorophenethylamine and 3-chlorobenzaldehyde are used as raw materials to prepare 1-(tetrahydropyrrole-1-methyl)-2-(6-chloro-3-oxo- 2,3-Dihydro-1H-indene-1-formyl)-7-fluoro-1,2,3,4-tetrahydroisoquinoline, and then react with methyl iodide, similar to the method in Example 1 to prepare I-2, white solid, yield 81.2%, m.p.190~192℃.
[0043] 1 H-NMR (300MHz, DMSO-d 6 ),δ(ppm):1.98~2.08(4H,m,2×CH 2 ),2.73~2.80(1H,d,J=18.6Hz,1 / 2CH 2 ),2.93~3.10(4H,m,1 / 2CH 2 ,CH 2 ,1 / 2CH 2 ),3.10(3H,s,NCH 3 ),3.48~3.82(4H,m,2×CH 2 ),3.92~4.06,4.13~4.32(2H,m,2×1 / 2CH 2 ),4.63~4.86(1H,m,1 / 2CH 2 ),5.04~5.06(1H,d,J=6.1Hz,CH),6.11~6.08(1H,d,J=10.1Hz,CH),7.12~7.18(1H,m,ArH),7.31~7.38(2H ,m,ArH),7.58~7.72(3H,m,ArH).
[0044] HRMS(ESI): m / z[M+H] + Calcd for C 25 H 27 ClFN 2 O 2 :...
Embodiment 3
[0046] 1-Methyl-1-((2-(6-chloro-3-oxo-2,3-dihydro-1H-indene-1-formyl)-6-methoxy-1,2, iodide 3,4-Tetrahydroisoquinolin-1-yl)-methyl)pyrrolium (I-3)
[0047] With reference to the method of Chinese patent CN1887872, using 3-methoxyphenethylamine and 3-chlorobenzaldehyde as raw materials, 1-(tetrahydropyrrole-1-methyl)-2-(6-chloro-3-oxygen) was prepared Substituted-2,3-dihydro-1H-indene-1-formyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline, and then reacted with methyl iodide, similar to Example 1 I-3 was prepared by the method of 1-3 as a white solid with a yield of 84.7%, m.p. 266~268°C.
[0048] 1 H-NMR (500MHz, DMSO-d 6 ),δ(ppm):1.94~2.08(4H,m,2×CH 2 ),2.72~2.78(1H,d,J=18.4Hz,1 / 2CH 2 ),2.85~3.06(4H,m,1 / 2CH 2 ,CH 2 ,1 / 2CH 2 ),3.09(3H,s,NCH 3 ),
[0049] 3.40~3.70(3H,m,CH 2 ,1 / 2CH 2 ),3.75~3.85(1H,m,1 / 2CH 2 ),3.75(3H,s,OCH 3 ),3.92~3.99,4.09~4.17(2H,m,2×1 / 2CH 2 ),4.59~4.62(1H,d,J=10.6Hz,1 / 2CH 2 ),5.04~5.05(1H,d,J=5.9Hz,CH),5.99~6.02(1H,d,J=10.0Hz,CH),6.83~6.87(2H,m...
PUM
| Property | Measurement | Unit |
|---|---|---|
| affinity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 